| Observer 1 n (%) | Observer 2 n (%) | Kappa | |
---|---|---|---|---|
CT | Biliary obstruction | 27 (52%) | 23 (44%) | 0.69 |
Capsular bulge/retraction | 31 (60%) | 17 (33%) | 0.50 | |
Enhancement pattern | Â | Â | 0.68 | |
 Peripheral progressive | 31 (60%) | 32 (62%) |  | |
 Persistent rim | 6 (12%) | 7 (13%) | ||
 Othera | 15 (28%) | 13 (25%) | ||
Satellite lesionsb | 14 (27%) | 12 (23%) | 0.69 | |
Vascular involvement | 17 (33%) | 21 (40%) | 0.59 | |
MRI | Biliary obstruction | 14 (39%) | 14 (39%) | 0.55 |
Capsular bulge/retraction | 16 (44%) | 7 (19%) | 0.47 | |
Enhancement pattern | Â | Â | 0.54 | |
 Peripheral progressive | 24 (66%) | 27 (75%) |  | |
 Persistent rim | 6 (17%) | 5 (14%) | ||
 Othera | 6 (17%) | 4 (11%) | ||
Satellite lesionsb | 7 (19%) | 5 (14%) | 0.60 | |
Vascular involvement | 13 (36%) | 9 (25%) | 0.57 | |
ADC (n = 19) | 5 (26%) | 9 (47%) | 0.93 | |
 Hypointense | 14 (74%) | 10 (53%) |  | |
 Other# |  |  | ||
DWI (n = 19) |  |  | 0.66 | |
 Hyperintense | 10 (53%) | 15 (79%) |  | |
 Targetoid | 6 (32%) | 4 (21%) |  | |
 Otherc | 3 (16%) | 0 (0%) |  | |
HBP (n = 12) |  |  | 1.00 | |
 Hypointense | 12 (100%) | 12 (100%) |  | |
 Otherd | 0 (0%) | 0 (0%) | ||
T2 (n = 36) |  |  | 0.29 | |
 Hyperintense | 21 (58%) | 24 (67%) |  | |
 Targetoid | 8 (22%) | 3 (8%) | ||
 Otherc | 7 (19%) | 9 (27%) |